AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
PRESS RELEASE AB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES…
35+ Rubber Sheets Launched, Duratuf Unveils Variety for OEMs and Contractors Worldwide
NEW DELHI and KOLKATA, India, Aug. 28, 2025 /PRNewswire/ -- Duratuf Products…
